Bremy Alburquerque

Bremy Alburquerque

Auto-generated profile, based on publicly available information

Bremy Alburquerque

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Science
Verified
Journal Article
Open access
PDF file
AGAna Silvia Gonzalez-Reiche
Ana Silvia Gonzalez-Reiche
MHMatthew M. Hernandez
Matthew M. Hernandez
MSMitchell J. Sullivan
Mitchell J. Sullivan
BCBrianne Ciferri
Brianne Ciferri
HAHala Alshammary
Hala Alshammary
HBHarm van Bakel
Harm van Bakel
Blighted Gotham: Deaths caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City (NYC) during the spring of 2020 have vastly exceeded those reported in China and many other countries. What were the early events that led to such a severe outbreak? Gonzalez-Reiche et al. sampled some of the early patients seeking assistance in February and March of 2020 at the Mount Sinai Health System. Phylogenetic analysis of virus sequences in these people, who were drawn from across NYC, showed that the virus had been independently introduced many times from Europe and elsewhere in the United States. Subsequent clusters of community transmission occurred. The focus of infection in NYC is a marker of the role this city plays as a two-way hub for human movement. Science this issue p. 297

3 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAna Silvia Gonzalez-Reiche
Ana Silvia Gonzalez-Reiche
HAHala Alshammary
Hala Alshammary
SSSarah Schaefer
Sarah Schaefer
GPGopi Patel
Gopi Patel
JPJose Polanco
Jose Polanco
HBHarm van Bakel
Harm van Bakel
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. Although intrahost evolution has been documented, direct evidence of subsequent transmission and continued stepwise adaptation is lacking. Here we describe sequential persistent SARS-CoV-2 infections in three individuals that led to the emergence, forward transmission, and continued evolution of a new Omicron sublineage, BA.1.23, over an eight-month period. The initially transmitted BA.1.23 variant encoded seven additional amino acid substitutions within the spike protein (E96D, R346T, L455W, K458M, A484V, H681R, A688V), and displayed substantial resistance to neutralization by sera from boosted and/or Omicron BA.1-infected study participants. Subsequent continued BA.1.23 replication resulted in additional substitutions in the spike protein (S254F, N448S, F456L, M458K, F981L, S982L) as well as in five other virus proteins. Our findings demonstrate not only that the Omicron BA.1 lineage can diverge further from its already exceptionally mutated genome but also that patients with persistent infections can transmit these viral variants. Thus, there is, an urgent need to implement strategies to prevent prolonged SARS-CoV-2 replication and to limit the spread of newly emerging, neutralization-resistant variants in vulnerable patients.

16 October 2018 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
TWTyler E. Wagner
Tyler E. Wagner
JBJacob R. Becraft
Jacob R. Becraft
KBKatie Bodner
Katie Bodner
BTBrian Teague
Brian Teague
XZXin Zhang
Xin Zhang
RWRon Weiss
Ron Weiss

20 January 2023 in Cell Host & Microbe
Verified
Journal Article
Open access
SDSophie Dyzenhaus
Sophie Dyzenhaus
MSMitchell J. Sullivan
Mitchell J. Sullivan
BABremy Alburquerque
Bremy Alburquerque
DBDaiane Boff
Daiane Boff
AGAdriana van de Guchte
Adriana van de Guchte
VTVictor Torres
Victor Torres
The epidemic community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 lineage has recently become a leading cause of hospital-associated bloodstream infections (BSIs). Here, we leveraged this recent introduction into hospitals and the limited genetic variation across USA300 isolates to identify mutations that contribute to its success in a new environment. We found that USA300 BSI isolates exhibit altered virulence regulation. Using comparative genomics to delineate the genes involved in this phenotype, we discovered repeated and independent mutations in the transcriptional regulator sarZ. Mutations in sarZ resulted in increased virulence of USA300 BSI isolates in a murine model of BSI. The sarZ mutations derepressed the expression and production of the surface protein ClfB, which was critical for the pathogenesis of USA300 BSI isolates. Altogether, these findings highlight ongoing evolution of a major MRSA lineage and suggest USA300 strains can optimize their fitness through altered regulation of virulence.

8 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMatthew M. Hernandez
Matthew M. Hernandez
AGAna Silvia Gonzalez-Reiche
Ana Silvia Gonzalez-Reiche
HAHala Alshammary
Hala Alshammary
SFShelcie Fabre
Shelcie Fabre
ZKZenab Khan
Zenab Khan
ESEmilia Mia Sordillo
Emilia Mia Sordillo
Numerous reports document the spread of SARS-CoV-2, but there is limited information on its introduction before the identification of a local case. This may lead to incorrect assumptions when modeling viral origins and transmission. Here, we utilize a sample pooling strategy to screen for previously undetected SARS-CoV-2 in de-identified, respiratory pathogen-negative nasopharyngeal specimens from 3,040 patients across the Mount Sinai Health System in New York. The patients had been previously evaluated for respiratory symptoms or influenza-like illness during the first 10 weeks of 2020. We identify SARS-CoV-2 RNA from specimens collected as early as 25 January 2020, and complete SARS-CoV-2 genome sequences from multiple pools of samples collected between late February and early March, documenting an increase prior to the later surge. Our results provide evidence of sporadic SARS-CoV-2 infections a full month before both the first officially documented case and emergence of New York as a COVID-19 epicenter in March 2020.

24 April 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ESErika Reategui Schwarz
Erika Reategui Schwarz
AGAdriana van de Guchte
Adriana van de Guchte
ADAmy C. Dupper
Amy C. Dupper
ACAna Berbel Caban
Ana Berbel Caban
DNDevika Nadkarni
Devika Nadkarni
DADeena R. Altman
Deena R. Altman
Background: Healthcare-associated infections pose a potentially fatal threat to patients worldwide and Staphylococcus aureus is one of the most common causes of healthcare-associated infections. S. aureus is a common commensal pathogen and a frequent cause of bacteremia, with studies demonstrating that nasal and blood isolates from single patients match more than 80% of the time. Here we report on a contemporary collection of colonizing isolates from those with methicillin-resistant S. aureus (MRSA) bloodstream infections to evaluate the diversity within hosts, and detail the clinical features associated with concomitant nasal colonization. Methods: Swabs of the bilateral anterior nares were obtained from patients diagnosed with MRSA bacteremia. A single colony culture from the blood and an average of 6 colonies from the nares were evaluated for MRSA growth. For the nares cultures, we typed multiple isolates for staphylococcal protein A (spa) and derived the clonal complexes. Demographic and clinical data were obtained retrospectively from the electronic medical record system and analysed using univariate and multivariable regression models. Results: Over an 11-month period, 68 patients were diagnosed with MRSA bloodstream infection, 53 were swabbed, and 37 (70%) were colonized with MRSA in the anterior nares. We performed molecular typing on 213 nasal colonies. Spa types and clonal complexes found in the blood were also detected in the nares in 95% of the cases. We also found that 11% of patients carried more than one clone of MRSA in the nares. Male sex and history of prior hospitalization within the past 90 days increased odds for MRSA colonization. Conclusion: The molecular epidemiological landscape of colonization in the setting of invasive disease is diverse and defining the interplay between colonization and invasive disease is critical to combating invasive MRSA disease.